Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit

Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection

NCT01084954 ·Status: COMPLETED

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

NCT01386489 ·Status: COMPLETED ·Phase: PHASE1

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

NCT00745368 ·Status: COMPLETED ·Phase: NA

Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption

NCT02463227 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

NCT06987318 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test

NCT06368453 ·Status: COMPLETED ·Phase: NA

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

NCT00514605 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Imaging Immune Activation in HIV by PET-MR

NCT03684655 ·Status: RECRUITING ·Phase: PHASE2

Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection

NCT00642707 ·Status: COMPLETED ·Phase: PHASE2

Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol

NCT04971343 ·Status: COMPLETED

HIV-1 Vaccine Test in Uninfected Adult Volunteers

NCT00047931 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity of COVID-19 Vaccination in PLWH

NCT04894448 ·Status: UNKNOWN

A Phase I Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004

NCT02042248 ·Status: COMPLETED ·Phase: PHASE1

Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001046 ·Status: WITHDRAWN ·Phase: PHASE1

Evaluating the Safety and Drug Levels of an Antibody Against HIV in Healthy, HIV-Uninfected Adults

NCT02165267 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

NCT01069809 ·Status: COMPLETED ·Phase: PHASE2

Inducing Immune Quiescence the Genital Tract With ASA

NCT03629327 ·Status: RECRUITING ·Phase: NA

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects

NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

NCT07047716 ·Status: RECRUITING ·Phase: PHASE3

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

NCT02591420 ·Status: COMPLETED ·Phase: PHASE1

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

NCT00238459 ·Status: COMPLETED

Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults

NCT01438606 ·Status: COMPLETED ·Phase: PHASE1

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

NCT00029445 ·Status: RECRUITING

Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T

NCT05529342 ·Status: ENROLLING_BY_INVITATION

Evaluating the Safety and Immune Response to Three HIV Vaccine Schedules in Healthy, HIV-Uninfected Adults

NCT01783977 ·Status: COMPLETED ·Phase: PHASE1